JulieRaniNangiaMD

Clinical Trials

• Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients Start of enrollment: 2004 Sep 01

  Completed

  Phase 2

• Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01

  Completed

  Phase 2

• Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors Start of enrollment: 2013 May 01

  Completed

  Phase 2

• High Dose Vitamin D vs Standard Dose Vitamin D Study Start of enrollment: 2013 Dec 01

  Terminated

  Phase 2

• CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer Start of enrollment: 2014 Jun 01

  Terminated

  Phase 1

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26

  Active, not recruiting

  Phase 3

• Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Start of enrollment: 2020 Dec 18

  Recruiting

  Phase 2

  Roles: Principal Investigator, Contact

• Join now to see all